Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Gonzalez Gonzalez D ^a   Gouma, D J ^a   Rauws, E A J ^a   Van Gulik, T M ^a   Bosma, A ^a   Koedooder, C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cholangiocarcinoma; Intraluminal brachytherapy; Radiotherapy; Surgery

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; AGED; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CHOLANGITIS; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DUODENUM STENOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

EID: 0344848558     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.s215     Document Type: Conference Paper

References (38)

1. Cameron JL, Pitt HA, Zinner MJ et al. Management of proximal cholangiocarcinoinas by surgical resection and radiotherapy. American Journal of Surgery 1990; 159: 91-97.
2. Kuvshinoff BW, Fong Y, Blumgart LH. Proximal bile duct tumors. (Review) (100 refs). Surgical Oncology Clinics of North America 1996; 5: 317-336.
3. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38
4. Klempnauer J, Ridder GJ, von Wasielewski R et al Resectional Surgery of Hilar Cholangiocarcinoma: A multivariate analysis of Prognostic Factors. Journal of Clinical Oncolog 1997; 15: 947-954.
5. Pitt HA, Nakeeb A, Abrams RA et at. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Annals of Surgery 1995; 221: 788-797.
6. Baer HU, Stain SC, Dennison AR et al. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 1993; 217: 20-27
7. Fortner JG, Vitelli CE, Maclean BJ. Proximal extrahepatic bile ducts tumors. Arch Surg 1989; 143: 1275-1279
8. Nordback IH, Pit HA, Colemen J et al. Unresectable hilar cholangiocarcinoma:Percutaneous versus operative palliation. Surgery 1994; 115: 597-603
9. Reding R, Buard JL, Lebeau G et al. Surgical management of 552 carcinomas of the extrahepatic bile ducts:Results of the French surgical association survey. Ann Surg 1991; 213: 236-241
10. Terblanche J, Kahn D, Bornman PC et al. The role of U tube palliative treatment in high bile duct carcinoma. Surgery 1988; 103: 624-632
11. Foo ML, Gunderson LL, Bender CE et al. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. International Journal of Radiation Oncology. Biology, Physics 1997; 39: 929-935.
12. Fritz P, Brambs HJ, Schraube P et al Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. International Journal of Radiation Oncology, Biology, Physics 1994; 29: 855-861.
13. Karani J, Fletcher M, Brinkley D et al. Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma. Clinical Radiology 1985; 36: 603-606.
14. Veeze-Kuijpers B, Meerwaldt JH, Lameris JS et al. The role of radiotherapy in the treatment of bile duct carcinoma. International Journal of Radiation Oncology, Biology, Physics 1990; 18: 63-67.
15. Gonzalez GD, Gerard JP, Maners AW et al. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Seminars in Liver Disease 1990; 10: 131-141.
16. Tollenaar RA, van de Velde CJ, Taat CW et al. External radiotherapy and extrahepatic bile duct cancer. European Journal of Surgery 1991; 157: 587-589.
17. Verbeek PC, Van Leeuwen DJ, Van Der Heyde MN et al Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients. Annales de Chirurgie 1991; 45: 350-354.
18. Schuster-Uitterhoeve AL, Gonzalez GD, Blank LE. Radiotherapy with multiple fractions per day in pancreatic and bile duct cancer. Radiotherapy & Oncology 1986; 7: 205-213.
19. Lygidakis NJ, Van Der Heyde MN, Verbeek PCM, et al. Technical considerations for the management of primary cholangiocarcinoma of the porta hepatis. Seminars in Liver Disease 1990; 10: 126-130
20. Kamada T, Saitou H, Takamura A et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. International Journal of Radiation Oncology, Biology, Physics 1996; 34: 767-774.
21. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. International Journal of Radiation Oncology, Biology, Physics 1994; 28: 945-951.
22. Schoenthaler R, Phillips TL, Castro J, et al. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Annals of Surgery 1994; 219: 267-274.
23. Tashiro S, Tsuji T, Kanemitsu K et al. Prolongation of survival for carcinoma at the hepatic duct confluence. Surgery 1993; 113: 270-278.
24. Lameris JS, Hesselink EJ, van Leeuwen PA et al. Ultrasound-Guided Percutaneous Transhepatic Cholangiography and Drainage in Patients With Hilar Cholangiocarcinoma. Seminars in Liver Diseases 1990; 10: 121-125.
25. Verbeek PCM, Van Der Heyde MN, Ramsoekh T et al.Clinical significance of implantation metastases after surgical treatment of cholangiocarcinoma. Seminars in Liver Diseases 1990; 10: 142-144.
26. Buskirk SJ, Gunderson LL, Schild SE et al. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Annals of Surgery 1992; 215: 125-131.
27. van der Hul RL, Plaisier PW, Lameris JS et al. Proximal cholangiocarcinomas: A multidisciplinary approach. European Journal of Surgery 1994; 160: 213-218.
28. Bowling TE, Galbraith SM, Hatfield AR et al. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996; 39: 852-855.
29. Ede RJ, Williams SJ, Hatfield AR, McIntyre S et al. Endoscopic management of inoperable cholangiocarcinoma using iridium-192. British Journal of Surgery 1989; 76: 867-869.
30. Lee CK, Barrios BR, Bjarnason H. Biliary tree malignancies: the University of Minnesota experience. Journal of Surgical Oncology 1997; 65: 298-305.
31. Mogavero GT, Jones B, Cameron JL et al. Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis: increased prevalence after radiation therapy. AJR 1992; American Journal of Roentgenology. 159: 1001-1003.
32. Mogavero GT, Jones B, Cameron JL et al. Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis: increased prevalence after radiation therapy. AJR 1992; American Journal of Roentgenology. 159: 1001-1003.
33. Monson JR, Donohue JH, Gunderson LL et al. Intraoperative radiotherapy for unresectable cholangiocarcinoma - the Mayo Clinic experience. Surgical Oncology 1992; 1: 283-290.
34. Todoroki T, Iwasaki Y, Okamura T et al. Intraoperative radiotherapy for advanced carcinoma of the biliary system. Cancer 1980; 46: 2179-2184.
35. Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. European Journal of Cancer 1998; 34: 977-986.
36. Koyama K, Tanaka J, Sato Yea. Experience in twenty patients with carcinoma of the hilar bile duct treated by resection, targeting chemotherapy and intracavitary irradiation. Surg Gynecol Obst 1993; 176: 239-245.
37. Mahe M, Romestaing P, Talon B. Radiation therapy for extrahepatic bile duct carcinoma. Radiotherapy & Oncology 1991, 21: 121-127
38. McMasters KM, Tuttle TM, Leach SD et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. American Jurnal of Surgery 1997, 174:605-608